Unlock instant, AI-driven research and patent intelligence for your innovation.

Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor

a technology of arylsulphones and arylsulphones, applied in the field of heterocyclic compounds, can solve the problems of their affinity and selectivity towards the 5htsub>6/sub>receptor or their pharmacological profile is not yet satisfactory

Active Publication Date: 2014-02-04
ABBOTT LAB INC +1
View PDF18 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

These compounds effectively treat a range of disorders associated with the 5HT6 receptor, including cognitive dysfunctions, schizophrenia, depression, and Parkinson's disease, by providing enhanced therapeutic properties and reduced side effects.

Problems solved by technology

However, their affinity and selectivity towards the 5HT6 receptor or their pharmacological profile is not yet satisfactory.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
  • Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
  • Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor

Examples

Experimental program
Comparison scheme
Effect test

preparation examples

I. Preparation of the Intermediates

a. Preparation of Sulfonyl Chlorides

a.1 3-Bromo-4-trifluoromethoxy-benzenesulfonyl chloride

[0278]2.0 g of 1-bromo-2-(trifluoro-methoxy)benzene (8.3 mmol) were dissolved in 30 ml of dichloromethane. At 0-5° C., 1.06 g of chlorosulfonic acid (9.13 mmol), dissolved in 3 ml of dichloromethane, were added dropwise. The reaction mixture was stirred for 30 min at room temperature. Additional 5.5 equivalents of chlorosulfonic in dichloromethane were added to drive the reaction to completion. Standard work-up was followed and silica gel chromatography with n-heptane-dichloromethane (6:4) as eluent gave 2.19 g of the title compound.

[0279]1H-NMR (CDCl3, 400 MHz): δ [ppm] 8.3 (d, 1H), 8.05 (dd, 1H), 7.5 (dd, 1H).

b. Preparation of 3-(3-aminophenyl)-pyrrolidines

b.1 1-(Methoxycarbonyl)-3-(3-aminophenyl)-pyrrolidine

b.1.1 1-(Methoxycarbonyl)-pyrroline

[0280]In a 5 l flask fitted with a mechanical stirrer and a thermocouple, were charged 500 g of powdered potassium c...

example 1

3-Trifluoromethoxy-N-[4-((S)-1-propyl-pyrrolidin-3-yl)-phenyl]-benzenesulfonamide and its hydrochloride

1.1 (S)-2-Phenyl-succinic acid dimethyl ester

[0290]5 g of (S)-2-phenyl succinic acid (25.75 mmol) were dissolved in 50 ml of methanol. At 4° C., 4.7 ml of thionyl chloride (64.37 mmol) were added dropwise. The reaction mixture was stirred at room temperature for 2 h, the solvents were evaporated under reduced pressure. The residue that remained was dissolved in diethyl ether, washed once with saturated aqueous NaHCO3 solution, reextracted with diethyl ether, and the combined organic layers dried over magnesium sulfate, filtered, and evaporated to dryness to yield 5.8 g of the desired product.

[0291]ESI-MS: 223.1 [M+H]+

1.2 (S)-2-Phenyl-butane-1,4-diol

[0292]2.54 g of lithium aluminium hydride (66.95 mmol) were suspended under ice cooling in 25 ml of tetrahydrofuran. 5.8 g of (S)-2-phenyl succinic acid dimethyl ester (25.75 mmol) dissolved in 25 ml of tetrahydrofuran were added slowly ...

example 2

4-Bromo-3-fluoro-N-[4-((S)-1-propyl-pyrrolidin-3-yl)-phenyl]-benzenesulfonamide

[0306]0.289 g of the desired product were obtained following the same synthetic procedure as described for 3-trifluoromethoxy-N-[4-((S)-1-propyl-pyrrolidin-3-yl)-phenyl]-benzenesulfonamide using commercially available 4-bromo-3-fluoro-benzenesulfonylchloride.

[0307]ESI-MS: 441.0 / 443.0 [M+H]+

[0308]1H-NMR (CDCl3): δ [ppm] 7.65 (m, 1H), 7.5 (m, 1H), 7.4 (m, 1H), 7.15 (d, 2H), 7.0 (d, 2H), 3.3 (m, 1H), 3.0 (m, 1H), 2.8 (m, 1H), 2.65 (m, 1H), 2.35-2.5 (m, 3H), 2.3 (m, 1H), 1.8 (m, 1H), 1.5 (m, 2H), 0.9 (m, 3H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
temperatureaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

The invention relates to compounds of the formula (I) wherein the variables have meanings given in the claims and the description. The invention also relates to the use of a compound of the formula (I) or a pharmaceutically acceptable salt thereof for preparing a medicament for the treatment of a medical disorder susceptible to the treatment with a 5HT6 receptor ligand.

Description

CROSS REFERENCE TO RELATED APPLICATION[0001]This application is a 371 national stage filing based upon International PCT Application No. PCT / EP2007 / 053807, with an international filing date of Apr. 18, 2007, which claims the benefit of priority to U.S. Provisional Application No. 60 / 793,139, filed Apr. 19, 2006, where International PCT Application No. PCT / EP2007 / 053807 is fully incorporated herein by reference as though fully set forth herein.BACKGROUND OF THE INVENTION[0002]The present invention relates to novel heterocyclic compounds. The compounds possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of the serotonine 5-HT6 receptor.[0003]Serotonin (5-hydroxytryptamine, 5HT), a monoamine neurotransmitter and local hormone, is formed by the hydroxylation and decarboxylation of tryptophan. The greatest concentration is found in the enterochromaffin cells of the gastrointestinal tract, the remainder being predominan...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(United States)
IPC IPC(8): C07D401/10C07D413/10A61K31/422A61K31/454A61K31/40A61K31/433C07D207/09A61K31/5377C07D403/10C07D417/10A61K31/4025A61K31/4245A61K31/427A61K31/4155C07D409/10
CPCC07D413/12C07D207/09C07D409/12C07D417/14C07D403/12C07D413/14C07D409/14C07D401/12C07D205/04C07D417/12C07D211/28A61P1/04A61P1/14A61P25/00A61P25/06A61P25/08A61P25/14A61P25/16A61P25/18A61P25/20A61P25/22A61P25/24A61P25/28A61P25/30A61P25/32A61P25/34A61P25/36A61P3/04A61P37/08A61P43/00A61P9/10A61K31/397
Inventor GRANDEL, ROLANDBRAJE, WILFRIED MARTINHAUPT, ANDREASTURNER, SEAN COLMLANGE, UDODRESCHER, KARLAUNGER, LILIANEPLATA, DAN
Owner ABBOTT LAB INC